neoadjuvant uveal melanoma

IDEAYA’s rare cancer drug shows promise as company lays out Phase III plans
Clinical Trials Arena
Tue, 09/24/24 - 11:54 am
IDEAYA Biosciences
clinical trials
darovasertib
neoadjuvant uveal melanoma